PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Global Biotechnology Market Expected to Undergo a Number of Transformations Finds IMARC Group - The biotechnology market is undergoing a number of transformations. These include a shift of growth towards emerging markets, increasing focus on monoclonal antibodies and an increasing penetration of biosimilars - IMARCgroup.com
Global Biotechnology Market Expected to Undergo a Number of Transformations Finds IMARC Group

 

NewswireToday - /newswire/ - Ghaziabad, Uttar Pradesh, India, 2013/04/19 - The biotechnology market is undergoing a number of transformations. These include a shift of growth towards emerging markets, increasing focus on monoclonal antibodies and an increasing penetration of biosimilars - IMARCgroup.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The global biotechnology market is expected to grow at a CAGR of 7% during 2013-2017 reaching sales worth nearly US$ 166 billion by 2017. This market, however, is expected to undergo a number of transformations which would impact the course of its growth. These transitions include a shift of growth from the developed to the emerging markets, an increasing focus on monoclonal antibodies compared to therapeutic proteins and an increasing penetration of biosimilars/follow-on-biologics compared to their branded versions. As a result of these transformations, the need for a user friendly, robust and comprehensive biotechnology market intelligence has become imperative for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the biotechnology market in some form or the other.

IMARC Group, one of the world’s leading research and advisory firms, introduces a new and revolutionary way to understand and evaluate the global biotechnology market with its new report entitled “Global Biopharmaceutical Market Report & Forecast: 2012-2017”. This report provides an analytical and statistical insight into the global biotechnology market. The study, which has been undertaken using desk based as well as primary market research is a must for: pharmaceutical manufacturers, biopharmaceutical manufacturers, drug delivery device manufacturers, PE firms, FDI investors, planning agencies, consultants, research firms, credit rating agencies, etc.

Regions/Countries Covered:
• North America: United States and Canada
• Latin America: Mexico, Brazil and Argentina
• Europe: Germany, France, Italy, Spain, United Kingdom, Russia and Turkey
• Asia Pacific: Japan, China, Australia, South Korea, India and Indonesia

Table of Contents
1. Market Definitions & Research Methodology
2. Analyst Briefing
3. Introduction to Biopharmaceuticals
4. Global Biopharmaceutical Market: Industry Analysis
4.1 Strengths
4.2 Weaknesses
4.3 Opportunities
4.4 Threats
5. Global Biopharmaceutical Market: Industry Performance
5.1 Market Performance & Forecast
5.2 Market Segmentation by Region
5.3 Market Segmentation by Indication
5.4 Market Segmentation by Class
6. North America
6.1 US
6.2 Canada
7. Latin America
7.1 Mexico
7.2 Brazil
7.3 Argentina
8. Europe
8.1 Germany
8.2 France
8.3 Italy
8.4 Spain
8.5 UK
8.6 Russia
8.7 Turkey
9. Asia Pacific
9.1 Japan
9.2 China
9.3 Australia
9.4 South Korea
9.5 India
9.6 Indonesia

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Global Biotechnology Market Expected to Undergo a Number of Transformations Finds IMARC Group

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Krishna Sharma - IMARCgroup.com 
+91 12 04155099 press[.]imarcgroup.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IMARC Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)